324 related articles for article (PubMed ID: 17897185)
1. A comparative study of the preventative effects exerted by three probiotics, Bifidobacterium lactis, Lactobacillus casei and Lactobacillus acidophilus, in the TNBS model of rat colitis.
Peran L; Camuesco D; Comalada M; Bailon E; Henriksson A; Xaus J; Zarzuelo A; Galvez J
J Appl Microbiol; 2007 Oct; 103(4):836-44. PubMed ID: 17897185
[TBL] [Abstract][Full Text] [Related]
2. Preventative effects of a probiotic, Lactobacillus salivarius ssp. salivarius, in the TNBS model of rat colitis.
Peran L; Camuesco D; Comalada M; Nieto A; Concha A; Diaz-Ropero MP; Olivares M; Xaus J; Zarzuelo A; Galvez J
World J Gastroenterol; 2005 Sep; 11(33):5185-92. PubMed ID: 16127750
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of the preventative effects exerted by two probiotics, Lactobacillus reuteri and Lactobacillus fermentum, in the trinitrobenzenesulfonic acid model of rat colitis.
Peran L; Sierra S; Comalada M; Lara-Villoslada F; Bailón E; Nieto A; Concha A; Olivares M; Zarzuelo A; Xaus J; Gálvez J
Br J Nutr; 2007 Jan; 97(1):96-103. PubMed ID: 17217564
[TBL] [Abstract][Full Text] [Related]
4. Lactobacillus fermentum, a probiotic capable to release glutathione, prevents colonic inflammation in the TNBS model of rat colitis.
Peran L; Camuesco D; Comalada M; Nieto A; Concha A; Adrio JL; Olivares M; Xaus J; Zarzuelo A; Galvez J
Int J Colorectal Dis; 2006 Dec; 21(8):737-46. PubMed ID: 16052308
[TBL] [Abstract][Full Text] [Related]
5. Prevention of TNBS-induced colitis by different Lactobacillus and Bifidobacterium strains is associated with an expansion of gammadeltaT and regulatory T cells of intestinal intraepithelial lymphocytes.
Roselli M; Finamore A; Nuccitelli S; Carnevali P; Brigidi P; Vitali B; Nobili F; Rami R; Garaguso I; Mengheri E
Inflamm Bowel Dis; 2009 Oct; 15(10):1526-36. PubMed ID: 19504616
[TBL] [Abstract][Full Text] [Related]
6. Participation of the intestinal microbiota in the mechanism of beneficial effect of treatment with synbiotic Syngut on experimental colitis under stress conditions.
Konturek PC; Konturek K; Brzozowski T; Wojcik D; Magierowski M; Targosz A; Krzysiek-Maczka G; Sliwowski Z; Strzalka M; Magierowska K; Szczyrk U; Kwiecien S; Ptak-Belowska A; Neurath M; Dieterich W; Wirtz S; Zopf Y
J Physiol Pharmacol; 2020 Jun; 71(3):. PubMed ID: 32991312
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulatory effects of Bifidobacterium bifidum 231 on trinitrobenzenesulfonic acid-induced ulcerative colitis in rats.
Satish Kumar CS; Kondal Reddy K; Boobalan G; Gopala Reddy A; Sudha Rani Chowdhary CH; Vinoth A; Jayakanth K; Srinivasa Rao G
Res Vet Sci; 2017 Feb; 110():40-46. PubMed ID: 28159236
[TBL] [Abstract][Full Text] [Related]
8. On the benefit of whey-cultured Lactobacillus casei in murine colitis.
Ghasemi-Niri SF; Abdolghaffari AH; Fallah-Benakohal S; Hosseinpour-Feizi M; Mahdaviani P; Jamalifar H; Baeeri M; Dehghan G; Abdollahi M
J Physiol Pharmacol; 2011 Jun; 62(3):341-6. PubMed ID: 21893695
[TBL] [Abstract][Full Text] [Related]
9. [Probiotic therapy using live combined bifidobacterium, lactobacillus and enterococcus for experimental colitis in rats model].
Wan YM; Zhu YQ; Xia B; Luo J
Zhonghua Nei Ke Za Zhi; 2010 May; 49(5):418-21. PubMed ID: 20646418
[TBL] [Abstract][Full Text] [Related]
10. Lactobacillus casei and bifidobacterium lactis supplementation reduces tissue damage of intestinal mucosa and liver after 2,4,6-trinitrobenzenesulfonic acid treatment in mice.
Bellavia M; Rappa F; Lo Bello M; Brecchia G; Tomasello G; Leone A; Spatola G; Uzzo ML; Bonaventura G; David S; Damiani P; Hajj Hussein I; Zeenny MN; Jurjus A; Schembri-Wismayer P; Cocchi M; Zummo G; Farina F; Gerbino A; Cappello F; Traina G
J Biol Regul Homeost Agents; 2014; 28(2):251-61. PubMed ID: 25001657
[TBL] [Abstract][Full Text] [Related]
11. Preventative effects of lactulose in the trinitrobenzenesulphonic acid model of rat colitis.
Camuesco D; Peran L; Comalada M; Nieto A; Di Stasi LC; Rodriguez-Cabezas ME; Concha A; Zarzuelo A; Galvez J
Inflamm Bowel Dis; 2005 Mar; 11(3):265-71. PubMed ID: 15735433
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential of two probiotics in inflammatory bowel disease as observed in the trinitrobenzene sulfonic acid model of colitis.
Amit-Romach E; Uni Z; Reifen R
Dis Colon Rectum; 2008 Dec; 51(12):1828-36. PubMed ID: 18633675
[TBL] [Abstract][Full Text] [Related]
13. Probiotic Yogurt Culture Bifidobacterium Animalis Subsp. Lactis BB-12 and Lactobacillus Acidophilus LA-5 Modulate the Cytokine Secretion by Peripheral Blood Mononuclear Cells from Patients with Ulcerative Colitis.
Sheikhi A; Shakerian M; Giti H; Baghaeifar M; Jafarzadeh A; Ghaed V; Heibor MR; Baharifar N; Dadafarin Z; Bashirpour G
Drug Res (Stuttg); 2016 Jun; 66(6):300-5. PubMed ID: 26909690
[TBL] [Abstract][Full Text] [Related]
14. Bifidobacterium and Lactobacillus improve inflammatory bowel disease in zebrafish of different ages by regulating the intestinal mucosal barrier and microbiota.
Ni Y; Zhang Y; Zheng L; Rong N; Yang Y; Gong P; Yang Y; Siwu X; Zhang C; Zhu L; Fu Z
Life Sci; 2023 Jul; 324():121699. PubMed ID: 37061125
[TBL] [Abstract][Full Text] [Related]
15. Intestinal anti-inflammatory activity of hydroalcoholic extracts of Phlomis purpurea L. and Phlomis lychnitis L. in the trinitrobenzenesulphonic acid model of rat colitis.
Algieri F; Zorrilla P; Rodriguez-Nogales A; Garrido-Mesa N; Bañuelos O; González-Tejero MR; Casares-Porcel M; Molero-Mesa J; Zarzuelo A; Utrilla MP; Rodriguez-Cabezas ME; Galvez J
J Ethnopharmacol; 2013 Apr; 146(3):750-9. PubMed ID: 23395625
[TBL] [Abstract][Full Text] [Related]
16. Mucosal colonisation with Lactobacillus casei mitigates barrier injury induced by exposure to trinitronbenzene sulphonic acid.
Llopis M; Antolín M; Guarner F; Salas A; Malagelada JR
Gut; 2005 Jul; 54(7):955-9. PubMed ID: 15951541
[TBL] [Abstract][Full Text] [Related]
17. Probiotic mixture supplementation in the preventive management of trinitrobenzenesulfonic acid-induced inflammation in a murine model.
Traina G; Menchetti L; Rappa F; Casagrande-Proietti P; Barbato O; Leonardi L; Carini F; Piro F; Brecchia G
J Biol Regul Homeost Agents; 2016; 30(3):895-901. PubMed ID: 27655518
[TBL] [Abstract][Full Text] [Related]
18. Intestinal anti-inflammatory activity of the seeds of Raphanus sativus L. in experimental ulcerative colitis models.
Choi KC; Cho SW; Kook SH; Chun SR; Bhattarai G; Poudel SB; Kim MK; Lee KY; Lee JC
J Ethnopharmacol; 2016 Feb; 179():55-65. PubMed ID: 26721217
[TBL] [Abstract][Full Text] [Related]
19. Intestinal anti-inflammatory activity of morin on chronic experimental colitis in the rat.
Gálvez J; Coelho G; Crespo ME; Cruz T; Rodríguez-Cabezas ME; Concha A; Gonzalez M; Zarzuelo A
Aliment Pharmacol Ther; 2001 Dec; 15(12):2027-39. PubMed ID: 11736735
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of tumor necrosis factor alpha and increased of interleukin 10 by
Jing L; Yu Z; Gao X; Liu C; Lv X; Zheng S
Immunopharmacol Immunotoxicol; 2019 Feb; 41(1):1-6. PubMed ID: 30821556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
